WSES-PSOGI-SICO 腹膜表面恶性肿瘤外科急症循证指南:系统评价、Meta 分析与结构化专家共识
该指南针对腹膜表面恶性肿瘤(PSM)患者恶性肠梗阻(MBO)的急诊管理,整合了系统评价、Meta 分析与德尔菲专家共识。系统评价纳入比较非随机研究与非比较研究,采用 ROBINS-I 与 MINORS 评估偏倚风险、GRADE 评级证据确定性。主要发现:药物治疗较手术/内镜治疗并发症更低(OR 0.16)且住院更短(MD -9.48 天);手术较内镜临床成功率更高(OR 2.57)但住院更长;手术选项中切除较旁路/造口围术期死亡风险更高(OR 3.55)。所有指南声明获投票参与者 100% 同意。
要点
- 在 PSM 相关 MBO 中,药物治疗与非手术/内镜操作相比,并发症更低(OR 0.16,95%CI 0.07-0.39)且住院时间更短(MD -9.48 天,95%CI -12.65 至 -6.32)。
- 非手术治疗失败后,手术较内镜临床成功率更高(OR 2.57,95%CI 1.47-4.50),但内镜缩短住院时间(MD 3.35 天,95%CI 1.46-5.23),两者死亡率无差异(OR 1.02,95%CI 0.70-1.49)。
- 在适合手术的患者中,肠切除较旁路或造口显示围术期死亡风险更高的信号(OR 3.55,95%CI 1.45-8.68)。
- 内镜支架置入的合并临床成功率为 0.71(95%CI 0.62-0.79);LAMS 的证据仅限于一项回顾性研究。
- 无比较诊断研究评估腹部 X 线或 Gastrografin 增强 X 线;两项小型回顾性 CT 系列支持使用增强 CT 定位梗阻并排除紧急并发症。
适用人群与场景
- 腹膜表面恶性肿瘤(PSM)患者,包括原发或继发于结直肠、胃、阑尾、妇科、胰胆及其他腹腔内或腹腔外肿瘤的腹膜种植。
- 急诊/ICU 场景中因恶性肠梗阻(MBO)就诊的 PSM 患者。
处置流程与药物剂量
- 诊断方面:无比较诊断研究评估腹部 X 线或 Gastrografin 增强 X 线在 PSM 相关 MBO 中的作用;两项小型回顾性 CT 系列支持使用增强 CT 定位梗阻并排除紧急并发症,但无法进行诊断性 Meta 分析。
- 药物治疗 vs 手术/内镜:药物治疗与更低并发症(OR 0.16,95%CI 0.07-0.39)和更短住院时间(MD -9.48 天,95%CI -12.65 至 -6.32)相关;成功率、死亡率和总生存期结论不确定。
- 非手术治疗失败后手术 vs 内镜:手术临床成功率更高(OR 2.57,95%CI 1.47-4.50);内镜缩短住院时间(MD 3.35 天,95%CI 1.46-5.23);死亡率无差异(OR 1.02,95%CI 0.70-1.49)。
- 手术方式选择:在适合手术的患者中,肠切除较旁路或造口显示围术期死亡风险更高的信号(OR 3.55,95%CI 1.45-8.68)。
- 内镜方式选择:内镜支架置入合并临床成功率为 0.71(95%CI 0.62-0.79);LAMS 的证据仅限于一项回顾性研究。
研究设计与关键结果
- 研究类型:系统评价、Meta 分析与结构化德尔菲专家共识,遵循 PRISMA、Cochrane 与 MOOSE 报告规范;检索 PubMed/MEDLINE 和 Cochrane Library 自建库至 2025 年 6 月(英语)。
- 纳入研究:五项预设 PICO/PIRT 问题分别涉及 CT/腹部 X 线/Gastrografin 增强 X 线的诊断作用、药物 vs 手术/内镜、非手术失败后手术 vs 内镜、手术候选者中肠切除 vs 造口/旁路、内镜候选者中内镜支架 vs EUS 引导 LAMS 旁路。
- 偏倚风险与证据确定性:比较性非随机研究用 ROBINS-I、非比较研究用 MINORS 评估偏倚风险;GRADE 评级证据确定性。
- Meta 分析:随机效应模型(REML)产生 OR、MD、合并均值或合并比例及 95%CI;异质性用 I2、τ2 和 95% 预测区间总结。
- 主要结果:药物治疗较手术/内镜并发症更低(OR 0.16,95%CI 0.07-0.39)且住院更短(MD -9.48 天,95%CI -12.65 至 -6.32);手术较内镜临床成功率更高(OR 2.57,95%CI 1.47-4.50),内镜住院更短(MD 3.35 天,95%CI 1.46-5.23),死亡率无差异(OR 1.02,95%CI 0.70-1.49);肠切除较旁路/造口围术期死亡风险更高信号(OR 3.55,95%CI 1.45-8.68);内镜支架合并临床成功率 0.71(95%CI 0.62-0.79)。
- 共识投票:所有指南声明在投票参与者中达到 100% 同意。
证据类型、等级与局限
- 证据类型:系统评价、Meta 分析与结构化专家共识(指南)。
- 证据确定性:采用 GRADE 评级,原文结论指出 available evidence 的确定性低。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在 PSM 相关 MBO 急诊决策中,可将药物治疗作为并发症更低、住院更短的选择,但成功率、死亡率和总生存期结论不确定。
- 非手术治疗失败后,手术临床成功率更高但住院更长,内镜住院更短但成功率较低,两者死亡率无差异;需结合患者情况个体化选择。
- 在适合手术的患者中,肠切除较旁路或造口围术期死亡风险更高的信号需在决策时权衡。
- 内镜支架置入合并临床成功率为 0.71,LAMS 证据仅限于一项回顾性研究,使用需谨慎。
- 作者认为,尽管证据确定性低,该共识框架可帮助外周和转诊医院协调诊疗,强调个体化多学科判断和未来更高质量证据的需要。
指南或共识出处
- WSES-PSOGI-SICO evidence-informed guidelines on surgical emergencies in patients with peritoneal surface malignancies: a systematic review, meta-analysis, and structured expert consensus(World J Emerg Surg)
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Peritoneal surface malignancies (PSM) are primary or secondary neoplastic deposits involving the peritoneum and are commonly associated with colorectal, gastric, appendiceal, gynecological, pancreaticobiliary, and other intra-abdominal or extra-abdominal cancers. Malignant bowel obstruction (MBO) is one of the most frequent and clinically consequential emergency presentations in this population, yet diagnostic and therapeutic pathways remain heterogeneous. We aimed to develop evidence-informed recommendations for emergency management of MBO in patients with PSM by integrating a systematic review, meta-analysis and a structured international expert consensus process.
METHODS: This systematic review, meta-analysis, and Delphi consensus followed PRISMA, Cochrane, and relevant MOOSE reporting principles. PubMed/MEDLINE and the Cochrane Library were searched from inception to June 2025 (English language). Five predefined PICO/PIRT questions addressed: (1) the diagnostic role of CT, plain abdominal X-ray, or Gastrografin-enhanced X-ray in PSM-related MBO; (2) nonoperative medical management versus surgical or endoscopic therapy; (3) surgical versus endoscopic treatment after failure of nonoperative management; (4) bowel resection versus stoma or bypass in surgical candidates; and (5) endoscopic stenting versus endoscopic ultrasound-guided bypass with lumen-apposing metal stents in endoscopic candidates. Study selection and data extraction were performed independently and in duplicate. Risk of bias was assessed with ROBINS-I for comparative non-randomized studies and MINORS for non-comparative studies; certainty of evidence was rated with GRADE. Random-effects meta-analyses (REML) produced odds ratios (OR), mean differences (MD), pooled means, or pooled proportions with 95% confidence intervals (CI); heterogeneity was summarized using I2, τ2, and 95% prediction intervals. Evidence profiles informed statements voted on by the WSES-PSOGI-SICO expert panel during the 2025 WSES Congress.
RESULTS: No comparative diagnostic study evaluated abdominal X-ray or Gastrografin-enhanced X-ray in PSM-related MBO; two small retrospective CT-based series supported contrast-enhanced CT for mapping obstruction and excluding urgent complications, but no diagnostic meta-analysis was possible. For medical versus procedural treatment, medical management was associated with lower morbidity (OR 0.16, 95% CI 0.07-0.39) and shorter length of stay (MD - 9.48 days, 95% CI - 12.65 to -6.32), while success, mortality, and overall survival remained inconclusive. For surgery versus endoscopy, surgery showed higher clinical success (OR 2.57, 95% CI 1.47-4.50), whereas endoscopy shortened hospital stay (MD 3.35 days, 95% CI 1.46-5.23); mortality did not differ (OR 1.02, 95% CI 0.70-1.49). Among surgical options, resection showed a signal toward higher perioperative mortality than bypass or ostomy (OR 3.55, 95% CI 1.45-8.68). Endoscopic stenting showed a pooled clinical success rate of 0.71 (95% CI 0.62-0.79), whereas evidence on LAMS was limited to one retrospective study. All guideline statements reached 100% agreement among voting participants.
CONCLUSIONS: Despite the low certainty of available evidence, integration of systematic review findings with expert consensus provides a structured international framework to support decision-making in emergency presentations of PSM-related MBO. These consensus-based recommendations are intended to assist clinicians in harmonizing care across peripheral and referral hospitals, while emphasizing individualized multidisciplinary judgement and the need for future higher-quality evidence.
参考来源
- Fugazzola P, Granieri S, Abu-Zidan F, et al. WSES-PSOGI-SICO evidence-infomed guidelines on surgical emergencies in patients with peritoneal surface malignancies: a systematic review, meta-analysis, and structured expert consensus. World J Emerg Surg. 2026. PMID: 42958307. doi:10.1186/s13017-026-00718-7
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。